Showing 1 - 7 results of 7 for search 'Po‐Jung Su', query time: 0.03s Refine Results
  1. 1
    Modifiable factors of depressive-symptom trajectories from caregiving through bereavement

    Modifiable factors of depressive-symptom trajectories from caregiving through bereavement by Fur-Hsing Wen, Wen-Chi Chou, Po-Jung Su, Ming-Mo Hou, Wen-Chi Shen, Mei Huang Hsu, Siew Tzuh Tang

    Published 2022-09-01
    Get full text
    Article
  2. 2
    CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.

    CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer. by Jayashri Mahalingam, Chun-Yen Lin, Jy-Ming Chiang, Po-Jung Su, Yu-Yi Chu, Hsin-Yi Lai, Jian-He Fang, Ching-Tai Huang, Yung-Chang Lin

    Published 2014-01-01
    Get full text
    Article
  3. 3
    A cost‐effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first‐line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan

    A cost‐effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first‐line maintenance treatment for patients with locally advanced or meta... by Po‐Jung Su, Ying Xiao, Amy Y. Lin, Connie Goh, Ethan Wu, Kevin Liu, Patrick Chou, Kaitlin Kuo, Roberto Palencia, Jane Chang, Mairead Kearney, Venediktos Kapetanakis, Agnes Benedict

    Published 2023-10-01
    Get full text
    Article
  4. 4
    Purely laparoscopic feeding jejunostomy: a procedure which deserves more attention

    Purely laparoscopic feeding jejunostomy: a procedure which deserves more attention by Hsin-I. Tsai, Ta-Chun Chou, Ming-Chin Yu, Chun-Nan Yeh, Meng-Ting Peng, Chia-Hsun Hsieh, Po-Jung Su, Chiao-En Wu, Yung-Chia Kuo, Chien-Chih Chiu, Chao-Wei Lee

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitors

    Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitors by Liang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, Chang-Ting Lin, Hao-Lun Luo, Chih-Chi Chou, Shih-Yu Huang, Chia-Che Wu, Chien-Hsu Chen, Chun-Chieh Huang, Kai-Lung Tsai, Harvey Yu-Li Su

    Published 2024-12-01
    Get full text
    Article
  6. 6
    The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy

    The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy by Tsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, Ming-Chun Kuo, Chang-Ting Lin, Chia-Che Wu, Hao-Lun Luo, Chien-Hsu Chen, Chih-Chi Chou, Ting-Ting Liu, Chun-Chieh Huang, Kai-Lung Tsai, Yu-Li Su

    Published 2023-09-01
    Get full text
    Article
  7. 7
    Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

    Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma... by Jason Chia‐Hsun Hsieh, Pin‐Chun Chiang, Tsung‐Min Hung, Yin‐Kai Chao, Yung‐Chia Kuo, Chih‐Tsung Wen, Po‐Jung Su, Meng‐Ting Peng, Huan‐Wu Chen, Hui‐Ling Liu, Hsien‐Kun Chang, Min‐Hsien Wu, Hung‐Ming Wang

    Published 2021-12-01
    Get full text
    Article

Search Tools: